T1	Participants 77 134	patients with severe acute respiratory distress syndrome:
T2	Participants 252 315	adult patients with acute respiratory distress syndrome (ARDS).
T3	Participants 444 460	40 ARDS patients
T4	Participants 534 558	Patients were randomized
